Skip to main content
Log in

A Case of Stevens-Johnson Syndrome, Cholestatic Hepatitis and Haemolytic Anaemia Associated with Use of Mefenamic Acid

  • Case Report
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

A woman with a history of drug allergy, renal impairment and carcinoma of the breast with pulmonary micrometastases developed haemolytic anaemia and Stevens-Johnson syndrome following the use of mefenamic acid, paracetamol (acetaminophen) and furosemide (frusemide). In addition there was severe cholestatic hepatitis in the absence of clinical evidence of sepsis, biliary obstruction or recurrent metastases. The rash resolved on steroid therapy but the patient eventually died from both renal and liver failure. Acute tubular necrosis with a background of chronic tubulointerstitial nephritis was also found at autopsy. Although in the presence of multiple drug therapy the causative agent cannot be identified with absolute certainty, the association of these severe idiosyncratic hepatic and dermatological reactions with haemolytic anaemia strongly suggests mefenamic acid as the most likely culprit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Araugo OE, Flowers FR. Stevens-Johnson syndrome. Journal of Emergency Medicine 2: 129–135, 1978

    Article  Google Scholar 

  • Baker LR, Cattell WR, Levison DA, Edelman JB. Mefenamic acid-induced interstitial nephritis and renal failure. Postgraduate Medical Journal 60: 82–83, 1984

    Article  PubMed  CAS  Google Scholar 

  • Boletis J, Williams AJ, Shortland JR, Brown CB. Irreversible renal failure following mefenamic acid. Nephron 51: 575–576, 1989

    Article  PubMed  CAS  Google Scholar 

  • Carmichael J, Skankel SW. Effects of non-steroidal anti-inflammatory drugs on prostaglandins and renal function. American Journal of Medicine 96: 992–1000, 1985

    Article  Google Scholar 

  • Clive DM, Stoff JS. Renal syndromes associated with non-steroidal anti-inflammatory drugs. New England Journal of Medicine 310: 563–571, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ciucci A. A review of spontaneously reported adverse drug reactions. Rheumatology and Rehabilitation (Suppl. 2): 116-121, 1979

  • Fowler PD. Aspirin, paracetamol and non-steroidal anti-inflammatory drugs: comparative review of side effects. Medical Toxicology 2: 338–366, 1987

    PubMed  CAS  Google Scholar 

  • Jenkins DA, Harrison DJ, MacDonald MK, Winney RJ. Mefenamic acid nephropathy: an interstitial and mesangial lesion. Nephrology Dialysis Transplantation 3: 217–220, 1988

    CAS  Google Scholar 

  • Kornberg A, Polliak A. Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet 2: 1159, 1978

    Article  PubMed  CAS  Google Scholar 

  • Prescott LF. Paracetamol overdose: pharmacological considerations and clinical management. Drugs 25: 290–314, 1983

    Article  PubMed  CAS  Google Scholar 

  • Prescott LF, Critchley JAJH, Balali-Mood M. Phenylbutazone overdosage: abnormal metabolism associated with hepatic and renal damage. British Medical Journal 281: 1106–1107, 1980

    Article  PubMed  CAS  Google Scholar 

  • Sanford-Driscoll M, Knodel LC. Induction of haemolytic anaemia by non-steroidal anti-inflammatory drugs. Drug Intelligence and Clinical Pharmacy 20: 925–934, 1986

    PubMed  CAS  Google Scholar 

  • Scott GL, Myles AB, Bacon PA. Autoimmune haemolytic anaemia and mefenamic acid. British Medical Journal 3: 534–535, 1968

    Article  PubMed  CAS  Google Scholar 

  • Shepherd AN, Ferguson J. Bewick M, Bouchier IA. Mefenamic acid-induced bullous pemphigoid. Postgraduate Medical Journal 62: 67–68, 1986

    Article  PubMed  CAS  Google Scholar 

  • Solez K. Pathogenesis of acute renal failure. International Review of Experimental Pathology 24: 277–333, 1983

    PubMed  CAS  Google Scholar 

  • Stern RS, Bigby M. Cutaneous reactions to non-steroidal anti-inflammatory drugs. Journal of the American Medical Association 252: 1433–1437, 1984

    Article  PubMed  CAS  Google Scholar 

  • Taha A, Lenton RJ, Murdoch PS, Peden NR. Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem. British Medical Journal 291: 661–662, 1985

    Article  PubMed  CAS  Google Scholar 

  • Watson A, Watt G. Fixed drug eruption to mefenamic acid. Australasian Journal of Dermatology 27: 6–7, 1986

    Article  PubMed  CAS  Google Scholar 

  • Weber JCP. Epidemiology of adverse reactions to non-steroidal anti-inflammatory drugs. In Rainsford & Velo (Eds) Advances in inflammatory research, Vol. 6, pp. 1–7, Raven Press, New York, 1984

    Google Scholar 

  • Zimmerman HJ, Lewis JH. Drug-induced cholestasis. Medical Toxicology 2: 112–160, 1987

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, J.C.N., Lai, F.M. & Critchley, J.A.J.H. A Case of Stevens-Johnson Syndrome, Cholestatic Hepatitis and Haemolytic Anaemia Associated with Use of Mefenamic Acid. Drug-Safety 6, 230–234 (1991). https://doi.org/10.2165/00002018-199106030-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199106030-00007

Keywords

Navigation